Physician profile
David Yen
NPI 1033174503
$1,393,545.03
in general payments reported to CMS, 2019-2025
37 companies · $246K in 2025
The $246K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $76K · 2020: $107K · 2021: $235K · 2022: $261K · 2023: $237K · 2024: $232K · 2025: $246K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $541K · Consulting Fee: $81K · Travel and Lodging: $69K · Food and Beverage: $24K · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $540,940.06 |
| Consulting Fee | $80,953.00 |
| Travel and Lodging | $69,194.30 |
| Food and Beverage | $23,572.67 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $586,495.44 | 2019-2025 | Dupixent |
| Genzyme Corporation | $521,416.62 | 2019-2025 | |
| Stryker Corporation | $158,630.49 | 2019-2024 | Scopis Ent |
| Medtronic, INC. | $65,957.88 | 2021-2025 | Propel, Straightshot, Fusion |
| Neurent Medical Limited | $40,303.34 | 2022-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Oyster Point Pharma, INC. | $8,050.00 | 2022 | |
| Aerin Medical INC. | $3,257.80 | 2022-2025 | |
| Genentech USA, INC. | $2,125.00 | 2020 | |
| Intuitive Surgical, INC. | $1,417.11 | 2020 | |
| Optinose US, INC. | $880.28 | 2019-2025 | |
| Medical Device Business Services, INC. | $832.84 | 2022 | |
| Glaxosmithkline, LLC. | $765.83 | 2020-2025 | Nucala |
| Acclarent, INC | $578.63 | 2019-2023 | Trudi Nav Cable, Acclarent Aera, Acclarent Navwire |
| Spirair, INC. | $319.58 | 2024-2025 | Septalign |
| Astrazeneca Pharmaceuticals LP | $301.49 | 2022-2025 | Fasenra, Airsupra, Tezspire |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $299.44 | 2025 | Inspire |
| Preceptis Medical, INC. | $283.93 | 2021-2023 | Hummingbird Tympanostomy Tube System |
| Biocryst US Sales Co., LLC | $185.80 | 2021-2025 | Orladeyo |
| Phathom Pharmaceuticals, INC. | $169.52 | 2024-2025 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $152.35 | 2025 | Cuvitru |
| Arrinex, INC. | $131.44 | 2019 | |
| Organogenesis INC. | $128.97 | 2023-2025 | Puraply, Affinity |
| Smith+Nephew, INC. | $119.80 | 2020-2024 | Halo, Tula |
| Biohaven Pharmaceutical Holding Company LTD. | $111.71 | 2022 | |
| Intersect Ent, INC. | $100.04 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $87.96 | 2021-2025 | Keytruda |
| Pfizer INC. | $75.32 | 2024-2025 | |
| Medtronic USA, INC. | $60.53 | 2019 | |
| Karl Storz Endoscopy-America | $52.25 | 2024 | Solo+ Ttd Handpiece |
| 3nt Medical | $50.12 | 2023 | |
| Hologic Sales and Service, LLC | $45.34 | 2023-2024 | Coolseal Generator |
| Biofire Diagnostics, LLC | $35.84 | 2019 | |
| Amgen INC. | $34.00 | 2025 | |
| Ionis Pharmaceuticals, INC. | $32.16 | 2025 | Dawnzera |
| Alk-Abello, INC | $31.21 | 2021 | |
| Covidien LP | $13.64 | 2019 | |
| Atos Medical INC | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$143,226.26 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Yen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.